AI-generated summary
The authors report a single-arm feasibility study of a stent-based low-level laser device in 15 patients receiving radiotherapy for head and neck cancer. Grade 3 or higher oral mucositis occurred in 6.6% of patients, which the authors describe as lower than historical rates of 30% to 40%. The device was reported as well tolerated, though the authors call for randomized trials to confirm these findings.
- Participants
- 15
- Who or what was studied
- Patients receiving curative radiotherapy for head and neck cancers
- Wavelengths
- 670, 830, 910 nm
- Limits stated in the abstract
- Small single-arm study without a control group, and the authors state that randomized trials are needed to confirm the findings.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on onlinelibrary.wiley.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 910 nm
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Low-level laser therapy, Laser, Oral mucositis, GRADE, Trial registration. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.